NAFLD相关肝细胞癌的预防:生活方式与化学预防的作用
本文综述了NAFLD相关肝细胞癌(HCC)预防策略的证据,涵盖减重、体力活动、吸烟、饮食模式及咖啡和酒精等生活方式因素的影响,并总结了阿司匹林、抗糖尿病治疗和他汀类药物的化学预防证据,同时简要回顾了辅助治疗在HCC三级预防中的作用。
要点
- 生活方式因素如减重、体力活动、饮食模式对NAFLD相关HCC风险有影响。
- 阿司匹林、抗糖尿病治疗和他汀类药物具有化学预防潜力。
- 辅助治疗在HCC三级预防中作用需进一步明确。
核心结论
- 预防NAFLD相关HCC需关注生活方式干预和化学预防策略。
研究设计与样本
- 综述,总结了NAFLD相关HCC预防策略的证据。
主要发现
- 减重、体力活动、吸烟、饮食模式及咖啡和酒精摄入与HCC及NAFLD/NASH相关。
- 阿司匹林、抗糖尿病治疗和他汀类药物有化学预防证据。
临床怎么用
- 临床可考虑生活方式干预和化学预防以降低NAFLD相关HCC风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing. Preventive strategies are needed to counteract this trend. In this review, we provide an overview of the evidence on preventive strategies in NAFLD-associated HCC. We consider the impact of lifestyle factors such as weight loss, physical activity, smoking, dietary patterns and food items, including coffee and alcohol, on both HCC and NAFLD/NASH. Furthermore, evidence on chemopreventive treatments, including aspirin, antidiabetic treatments and statins is summarised. The role of adjuvant therapies for tertiary prevention of HCC is briefly reviewed.
引用
- Lange NF, Radu P, Dufour JF, et al. Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. J Hepatol. 2021. PMID: 34339764. doi:10.1016/j.jhep.2021.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。